March 3, 2016March 4, 2016

For Crohn’s Disease and Ulcerative Colitis, Company Reveals Results of New Study and Is Recruiting for Clinical Trial

Crohn's Disease, IBD News, News, Ulcerative colitis

Immune Pharmaceuticals recently published new data on the impact of eotaxin-1 in ulcerative colitis (UC) and Crohn’s disease (CD). The article, “The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New ... Read more

December 2, 2015May 17, 2016

Immune Pharmaceuticals Initiates Phase 2 Clinical Trial with Bertilimumab for Ulcerative Colitis Treatment

News, Ulcerative colitis

Immune Pharmaceuticals, Inc. recently announced the enrollment of the first patient in its Phase 2 clinical trial to assess the safety and efficacy of the first-in-class, entirely human monoclonal antibody bertilimumab for ... Read more